Your browser doesn't support javascript.
loading
QbD-Assisted Development and Optimization of Doxycycline Hyclate- and Hydroxyapatite-Loaded Nanoparticles for Periodontal Delivery.
Jain, Pooja; Mirza, Mohd Aamir; Reyaz, Enam; Beg, Mirza Adil; Selvapandiyan, Angamuthu; Hasan, Nazeer; Naqvi, Akbar; Punnoth Poonkuzhi, Naseef; Kuruniyan, Mohammad Saheer; Yadav, Harlokesh Narayan; Ahmad, Farhan J; Iqbal, Zeenat.
Afiliação
  • Jain P; Department of Pharmaceutics, School of Pharmaceutical Education and Research, SPER, Jamia Hamdard, New Delhi 110062, India.
  • Mirza MA; Department of Pharmaceutics, School of Pharmaceutical Education and Research, SPER, Jamia Hamdard, New Delhi 110062, India.
  • Reyaz E; Department of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.
  • Beg MA; Department of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.
  • Selvapandiyan A; Department of Molecular Medicine, Jamia Hamdard, New Delhi 110062, India.
  • Hasan N; Department of Pharmaceutics, School of Pharmaceutical Education and Research, SPER, Jamia Hamdard, New Delhi 110062, India.
  • Naqvi A; Department of Dentistry, HIMSR, New Delhi 110062, India.
  • Punnoth Poonkuzhi N; Department of Pharmaceutics, Moulana College of Pharmacy, Perinthalmanna, Kerala 679321, India.
  • Kuruniyan MS; Department of Dental Technology, COAMS, King Khalid University. Abha 61421, Saudi Arabia.
  • Yadav HN; Department of Pharmacology, AIIMS, New Delhi, 110608, India.
  • Ahmad FJ; Department of Pharmaceutics, School of Pharmaceutical Education and Research, SPER, Jamia Hamdard, New Delhi 110062, India.
  • Iqbal Z; Department of Pharmaceutics, School of Pharmaceutical Education and Research, SPER, Jamia Hamdard, New Delhi 110062, India.
ACS Omega ; 9(4): 4455-4465, 2024 Jan 30.
Article em En | MEDLINE | ID: mdl-38313517
ABSTRACT
The current research aims to develop a carrier system for the delivery of a matrix metalloproteinase (MMP) inhibitor along with a bioceramic agent to the periodontal pocket. It is proposed that the present system, if given along with a systemic antibiotic, would be a fruitful approach for periodontitis amelioration. To fulfill the aforementioned objective, a doxycycline hyclate- and hydroxyapatite-adsorbed composite was prepared by a physical adsorption method and successfully loaded inside sodium alginate-chitosan nanoparticles and optimized based on particle size and drug content. Optimized formulation was then subjected to different evaluation parameters like encapsulation efficiency, hydroxyapatite content, ζ potential, surface morphology, in vitro drug release, cell line studies, and stability studies. For the optimized formulation, particle size, polydispersity index (PDI), entrapment efficiency, ζ potential, and drug content were found to be 336.50 nm, 0.23, 41.77%, -13.85 mV, and 14.00%, respectively. The surface morphology of the placebo and adsorbed composite-loaded nanoparticles as observed by scanning electron microscopy (SEM) and transmission electron microscopy (TEM) revealed the spherical shape and rough surface of the particles. In gingival crevicular fluid (GCF) 7.6, a sustained drug release profile was obtained up to 36 h. In vitro % viability studies performed on murine fibroblast cells (NIH3T3) and human periodontal ligament (hPDL) cell lines confirmed the proliferative nature of the formulation. Also, when subjected to stability studies for 4 weeks, particle size, PDI, and drug content did not vary considerably, thereby ensuring the stable nature of nanoparticles. Henceforth, sodium alginate-chitosan nanoparticles appeared to be a good carrier system for doxycycline hyclate and hydroxyapatite for periodontal therapy. If given along with a system antibiotic, the system will serve as a fruitful tool for infection-mediated periodontal regeneration and healing.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: ACS Omega Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: ACS Omega Ano de publicação: 2024 Tipo de documento: Article